IGF-1 LR3 0.1mg
Insulin-like Growth Factor 1 Long R3
Modified 83-amino-acid IGF-1 with N-terminal extension and Arg3 substitution
Overview
IGF-1 LR3 0.1mg contains the same IGF-1 LR3 analogue as the 1mg product — a modified insulin-like growth factor 1 with dramatically reduced IGFBP binding and enhanced bioavailability. It activates the IGF-1 receptor to promote cell survival, proliferation, and growth through PI3K/Akt and Ras/MAPK signaling pathways. The 0.1mg vial is suited for smaller-scale research protocols, initial dose-finding studies, or individual cell culture experiments where less total material is needed. See the IGF-1 LR3 1mg entry for comprehensive research details.
Mechanism of Action
IGF-1 LR3 0.1mg contains the same IGF-1 LR3 analogue as the 1mg product — a modified insulin-like growth factor 1 with dramatically reduced IGFBP binding and enhanced bioavailability. It activates the IGF-1 receptor to promote cell survival, proliferation, and growth through PI3K/Akt and Ras/MAPK signaling pathways. The 0.1mg vial is suited for smaller-scale research protocols, initial dose-finding studies, or individual cell culture experiments where less total material is needed. See the IGF-1 LR3 1mg entry for comprehensive research details.
Key Research Findings
- Francis et al. (1992) demonstrated IGF-1 LR3 has reduced IGFBP binding and enhanced potency compared to native IGF-1.
- Tomas et al. (1993) showed IGF-1 LR3 is approximately 3-fold more potent than native IGF-1 in promoting growth.
- Clemmons (2007) reviewed the IGF/IGFBP system and IGFBP-resistant IGF analogues.
Citations & References
Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I
Francis GL, Ross M, Ballard FJ, et al. — J Mol Endocrinol (1992)
Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer
Clemmons DR. — Nat Rev Drug Discov (2007)
Dosage in Research
Cell culture: 50-100 ng/mL. The 0.1mg vial is appropriate for limited cell culture experiments or pilot studies.
Dosage information is derived from published research literature and is presented for educational purposes only. This is not medical advice. All products are for laboratory research use only.
Storage & Handling
Store lyophilized (freeze-dried) powder at -20°C to 4°C in a dry environment protected from light. Unreconstituted peptide is stable for extended periods when stored properly.
Once reconstituted with bacteriostatic water or an appropriate solvent, store at 2-8°C and use within the timeframe specified on the Certificate of Analysis. Avoid repeated freeze-thaw cycles.
A Certificate of Analysis documenting purity, identity, and recommended storage conditions is included with every order.
Frequently Asked Questions
What is IGF-1 LR3 0.1mg?
What purity is your IGF-1 LR3 0.1mg?
How should I store IGF-1 LR3 0.1mg?
Is IGF-1 LR3 0.1mg for human use?
Where can I buy IGF-1 LR3 0.1mg?
Research Use Only
All products are intended for laboratory research and educational purposes only. Products have not been evaluated by the FDA and are not intended for human consumption, diagnosis, treatment, or prevention of any disease. Purchasers must be 21+ and confirm research use intent.